Your browser doesn't support javascript.
loading
Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosis.
Gupta, Vikas; Gotlib, Jason; Radich, Jerald P; Kröger, Nicolaus M; Rondelli, Damiano; Verstovsek, Srdan; Deeg, H Joachim.
Affiliation
  • Gupta V; Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • Gotlib J; Stanford University School of Medicine, Palo Alto, California.
  • Radich JP; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Kröger NM; University Medical Center, Hamburg, Germany.
  • Rondelli D; University of Illinois College of Medicine at Chicago, Chicago, Illinois.
  • Verstovsek S; Leukemia Department, MD Anderson Cancer Center, Houston, Texas.
  • Deeg HJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. Electronic address: blarson@fhcrc.org.
Biol Blood Marrow Transplant ; 20(9): 1274-81, 2014 Sep.
Article in En | MEDLINE | ID: mdl-24680977

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transplantation, Homologous / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning / Janus Kinases / Primary Myelofibrosis Type of study: Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2014 Document type: Article Affiliation country: Canada Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transplantation, Homologous / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning / Janus Kinases / Primary Myelofibrosis Type of study: Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2014 Document type: Article Affiliation country: Canada Country of publication: United States